Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Shashank Patel

1PUBLICATIONS
11CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Mar 01, 2024
The FLRT3-UNC5B checkpoint pathway inhibits T cell-based cancer immunotherapies.

Kushal Prajapati, Chuan Yan, Qiqi Yang

Pageof 1

Frequent Collaborators

1 joint publications

Kushal Prajapati

1 joint publications

Chuan Yan

1 joint publications

Qiqi Yang

1 joint publications

Steven Arbitman

1 joint publications

Daniel P Fitzgerald

1 joint publications

Jason Bosiacki

1 joint publications

Kayla Myers

1 joint publications

Dorothy M Johnson

1 joint publications

Thomas O'Neill

1 joint publications

Solomon Langermann

Frequent Collaborators

1 joint publications

Kushal Prajapati

1 joint publications

Chuan Yan

1 joint publications

Qiqi Yang

1 joint publications

Steven Arbitman

Top Related Videos

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

310
See more related videos

Top Related Videos

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

310
See more related videos